Meta-analysis: The effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 2, 2007, Pages 155-168

  Tong, J L ^a   Ran, Z H ^a   Shen, J ^a   Zhang, C X ^b   Xiao, S D ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Department of Pharmacy   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; CLARITHROMYCIN; ESOMEPRAZOLE; FURAZOLIDONE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; TINIDAZOLE;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; DATA EXTRACTION; DIARRHEA; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGASTRIC PAIN; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFORMATION PROCESSING; MEDICAL RECORD REVIEW; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SUPPLEMENTATION; SYSTEMATIC REVIEW; TASTE DISORDER; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST;

ANTI-BACTERIAL AGENTS; DRUG COMBINATIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS;

EID: 33846012178     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03179.x     Document Type: Article

References (53)

1. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16 (Suppl. 1): 3-15.
2. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
3. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993; 88: 1870-5.
4. Boot H, de Jong D, van Heerde P, et al. Role of Helicobacter pylori eradication in high-grade MALT lymphoma. Lancet 1995; 346: 448-9.
5. Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 1669-75.
6. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol Suppl 1993; 196: 34-37.
7. Bell GD, Powell K, Burridge SM, et al. Experience with 'triple' anti- Helicobacter pylori eradication therapy: side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427-35.
8. Kabir AM, Aiba Y, Takagi A, et al. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41: 49-55.
9. Aiba Y, Suzuki N, Kabir AM, et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93: 2097-101.
10. Pinchuk IV, Bressollier P, Verneuil B, et al. In vitro anti- Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 2001; 45: 3156-61.
11. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
12. Goldman CG, Barrado DA, Balcarce N, et al. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006; [Epub ahead of print].
13. Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side effects of anti- Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004; 20: 1181-8.
14. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163-9.
15. Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63: 1-7.
16. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti- Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-9.
17. Myllyluoma E, Veijola L, Ahlroos T, et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebocontrolled, double-blind randomized pilot study. Aliment Pharmacol Ther 2005; 21: 1263-72.
18. Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14: 1625-9.
19. Duman DG, Bor S, Ozutemiz O, et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhea due to Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2005; 17: 1357-61.
20. Sykora J, Valeckova K, Amlerova J, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692-8.
21. Tursi A, Brandimarte G, Giorgetti GM, et al. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 2004; 10: CR662-6.
22. Sheu BS, Cheng HC, Kao AW, et al. Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 2006; 83: 864-9.
23. Gotteland M, Poliak L, Cruchet S, et al. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatr 2005; 94: 1747-51.
24. Opekun AR, Yeh CW, Opekun JL, et al. In vivo tests of natural therapy, Tibetan yogurt or fresh broccoli, for Helicobacter pylori infection. Methods Find Exp Clin Pharmacol 2005; 27: 327-9.
25. Wang KY, Li SN, Liu CS, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737-41.
26. Pantoflickova D, Corthesy-Theulaz I, Dorta G, et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Aliment Pharmacol Ther 2003; 18: 805-13.
27. Cruchet S, Obregon MC, Salazar G, et al. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003; 19: 716-21.
28. Gotteland M, Cruchet S. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother 2003; 51: 1317-9.
29. Shimizu T, Haruna H, Hisada K, et al. (LG21) on Helicobacter pylori infection in children. J Antimicrob Chemother 2716 2002; 617-8.
30. Wendakoon CN, Thomson AB, Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 2002; 65: 16-20.
31. Sakamoto I, Igarashi M, Kimura K, et al. (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2716 2001; 709-10.
32. Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60: 203-9.
33. Shimbo I, Yamaguchi T, Odaka T, et al. Effect of Clostridium butyricumon fecal flora in Helicobacter pylori eradication therapy. World J Gastroenterol 2005; 11: 7520-24.
34. Iakovenko EP, Grigor'ev PI, Iakovenko AV, et al. Effects of probiotic bifiform on efficacy of Helicobacter pylori infection treatment. Ter Arkh 2006; 72: 21-26.
35. Wendakoon CN, Thomson AB, Ozimek L, et al. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 2002; 65: 16-20.
36. Lykova EA, Bondarenko VM, Sidorenko SV, et al. Combined antibacterial and probiotic therapy of Helicobacter-associated diseases in children. Zh Mikrobiol Epidemiol Immunobiol 1999; 2: 76-81.
37. De Francesco V, Stoppino V, Sgarro C, et al. Lactobacillus acidophilus administration added to omeprazole/amoxycillin-based double therapy in Helicobacter pylori eradication. Dig Liver Dis 2000; 32: 746-7.
38. Abayli B, Colakoglu S, Serin M, et al. Helicobacter pylori in the etiology of cholesterol gallstones. J Clin Gastroenterol 2005; 39: 134-7.
39. Linsalata M, Russo F, Berloco P, et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004; 9: 165-72.
40. Plummer SF, Garaiova I, Sarvotham T, et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents 2005; 26: 67-74.
41. Madden JA, Plummer SF, Tang J, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol 2005; 5: 1091-7.
42. Guo JB, Yang PF, Wang MT, et al. The application of clostridium to the eradication of Helicobacter pylori. Chin J Celiopathy 2004; 4: 163-5.
43. Cao YJ, Qu CM, Yuan Q, et al. Control of intestinal flora alteration induced by eradication therapy of Helicobacter pylori infection in the elders. Chin J Gastroenterol Hepatol 2005; 14: 195-9.
44. Fuller R. Probiotics in human medicine. Ann Med 1990; 22: 37-41.
45. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130 (Suppl. 2S): 396S-402S.
46. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 2003; 17: 741-54.
47. Bhatia SJ, Kochar N, Abraham P, et al. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989; 27: 2328-30.
48. Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60: 203-9.
49. Borruel N, Casellas F, Antolin M, et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 2003; 98: 865-70.
50. Coconnier MH, Lievin V, Hemery E, et al. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64: 4573-80.
51. Lorca GL, Wadstrom T, Valdez GF, et al. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 2001; 42: 39-44.
52. Collado MC, Gonzalez A, Gonzalez R, et al. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents 2005; 25: 385-91.
53. Wang KY, Li SN, Liu CS, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737-41.